ARVINAS SHARES NOVEL OCULOMOTOR AND BIOMARKER DATA FROM PHASE 1 CLINICAL TRIAL OF ARV-102 IN PATIENTS WITH PARKINSON’S DISEASE

Reuters · 1d ago

Please log in to view news